Clinical Trial

Wearable Blood-Pressure Monitoring Comparison Study

Study acronym: WBPMCS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to compare the accuracy, clinical applicability, and usability of different wearable blood pressure monitoring methods integrated in wearable devices, such as smartwatches, in hospitalized patients. The study evaluates novel photoplethysmography (PPG)-based and wrist-oscillometric blood pressure measurement methods against established clinical reference methods (upper-arm cuff measurements on the general ward and invasive arterial blood pressure monitoring (A-line) in the intensive care unit). The main questions the study aims to answer are: * Can novel blood pressure monitoring methods suitable for integration into wearable devices achieve clinically acceptable agreement with established reference measurements? * How does the performance of calibration-dependent wearable devices change over time following calibration? * How does the performance of the investigated methods compare with each other? * How do the investigated methods perform for patients with different pre-existing conditions ? To answer these questions, participants will undergo: * blood pressure measurements using different wearable devices based on PPG and wrist oscillometry * standardized reference blood pressure measurements using an upper-arm cuff (general ward) or an existing invasive arterial line (intensive care unit) * repeated measurements over three consecutive days on the general ward to assess calibration stability and measurement reproducibility,
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-18.
Trial Details
NCT Number NCT07719660
Lead Sponsor Technische Universität Dresden
Collaborators: Careggi Hospital
Conditions Hypertension, Blood Pressure Monitoring, Wearable Devices, Photoplethysmography, Cuff
Enrollment 120 participants
Start Date 2026-07-20
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-23